|
News Boston Scientific Receives FDA Approval for New Infinion™ 16 Percutaneous Lead for Precision Plus Spinal Cord Stimulator System
Boston Scientific Corporation (NYSE: BSX) announces U.S. Food and Drug Administration (FDA) approval of the Infinion™ 16 Percutaneous Lead for its Precision Plus™ Spinal Cord Stimulator (SCS) System, the first rechargeable SCS device for chronic pain management. |